Key Laboratory of Natural Medicines of the Changbai Mountain, Ministry of Education, College of Pharmacy, Yanbian University, Yanji, 133002, China; Institute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Inner Mongolia Autonomous Region, Tongliao, 028000, China; Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, 028000, Inner Mongolia, PR China.
Institute of Pharmaceutical Chemistry and Pharmacology, Inner Mongolia Minzu University, Inner Mongolia Autonomous Region, Tongliao, 028000, China; Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, 028000, Inner Mongolia, PR China.
J Ethnopharmacol. 2022 Sep 15;295:115343. doi: 10.1016/j.jep.2022.115343. Epub 2022 May 6.
Forsythia suspensa (Thunb.) Vahl and Fritillaria thunbergii Miq are traditional Chinese medicines that exhibit the ability to clear heat and toxic material effects. In China, the combination of these two medicines is widely used to treat mucopurulent sputum and bloody phlegm, arising due to phlegm-heat obstruction in respiratory diseases. However, very limited information is available regarding the combined anti-inflammatory effect of important effective components of Forsythia suspensa (Thunb.) Vahl and Fritillaria thunbergii Miq, namely peimine, peiminine, and forsythoside A.
To investigate synergistic anti-inflammatory effects of combined administration of peimine, peiminine, and forsythoside A on LPS-induced acute lung injury compared to combined administration of two compounds or individual administration, and unravel the underlying mechanism.
In the present study, male BALB/c mice received an oral dosage of sodium carboxymethylcellulose (CMC-Na) (0.5%, 1 mL/100 g), peimine, peiminine, forsythoside A, peimine + forsythoside A, peiminine + forsythoside A, and peimine + peiminine + forsythoside A (suspended in CMC-Na; 0.5%), once daily for 7 days. Subsequently, intratracheal instillation of LPS was applied to establish acute lung injury model. After 6 h of administration, the mice were sacrificed, and bronchoalveolar lavage fluid (BALF) and lung tissues were collected. These samples were further used to determine lung W/D (wet/dry) weight ratio, total protein (TP) levels, inflammatory cytokines (IL-6, TNF-α, IL-1β, and IL-17), and expression of proteins involved in TLR4/MAPK/NF-κB pathway and IL-17 pathway. Further, tissue sections were subjected to H&E staining to assess the pathological alterations induced by LPS. The expression of IL-6 and TNF-α proteins in lung tissues was also analyzed using immunohistochemical staining.
A synergistic anti-inflammatory effect of peimine, peiminine, and forsythoside A was observed when administered in combination to LPS-induced acute lung injury. The combined administration of peimine, peiminine, and forsythoside A had a strongly inhibitory effects on the W/D weight ratio, total protein (TP) level and the inflammatory cytokines (TNF-α, IL-6, IL-1β, and IL-17) level in acute lung injury mice, compared to combined administration of two compounds or individual administration. The infiltration of inflammatory cells and thickened bronchoalveolar walls induced by LPS were also ameliorated through the combined administration of peimine, peiminine, and forsythoside A. More importantly, the upregulation of protein related to TLR4/MAPK/NF-κB signaling pathway and the activation of IL-17 were significantly suppressed by pretreatment with each of the three compounds alone, while the effects of individual compounds were synergistically augmented by the combined pretreatment of these three compounds.
The combined administration of peimine, peiminine, and forsythoside A ameliorated inflammatory response in acute lung injury mice induced by LPS in a synergistic manner, the mechanism may be related to the dampening of the TLR4/MAPK/NF-κB signaling pathway and IL-17 activation.
连翘(Thunb.)和川贝母(Miq.)是传统的中药,具有清热、解毒的作用。在中国,这两种药物的组合被广泛用于治疗因痰热阻肺而引起的粘脓性痰和血性痰的呼吸道疾病。然而,关于连翘(Thunb.)和川贝母(Miq.)的重要有效成分(如毛蕊异黄酮、毛蕊异黄酮苷和连翘酯苷 A)联合抗炎作用的信息非常有限。
研究毛蕊异黄酮、毛蕊异黄酮苷和连翘酯苷 A 联合给药对 LPS 诱导的急性肺损伤的协同抗炎作用,并与两种化合物联合给药或单独给药进行比较,以揭示其潜在机制。
在本研究中,雄性 BALB/c 小鼠接受羧甲基纤维素钠(CMC-Na)(0.5%,1mL/100g)、毛蕊异黄酮、毛蕊异黄酮苷、连翘酯苷 A、毛蕊异黄酮+连翘酯苷 A、毛蕊异黄酮苷+连翘酯苷 A 和毛蕊异黄酮+毛蕊异黄酮苷+连翘酯苷 A(悬浮在 CMC-Na 中;0.5%)的口服剂量,每天一次,共 7 天。随后,通过气管内滴注 LPS 建立急性肺损伤模型。给药 6 小时后,处死小鼠,收集支气管肺泡灌洗液(BALF)和肺组织。进一步使用这些样本来确定肺 W/D(湿/干)重量比、总蛋白(TP)水平、炎症细胞因子(IL-6、TNF-α、IL-1β 和 IL-17)以及 TLR4/MAPK/NF-κB 通路和 IL-17 通路中涉及的蛋白质的表达。进一步对组织切片进行 H&E 染色,以评估 LPS 诱导的病理改变。还使用免疫组织化学染色分析肺组织中 IL-6 和 TNF-α 蛋白的表达。
毛蕊异黄酮、毛蕊异黄酮苷和连翘酯苷 A 联合给药对 LPS 诱导的急性肺损伤具有协同抗炎作用。与两种化合物联合给药或单独给药相比,毛蕊异黄酮、毛蕊异黄酮苷和连翘酯苷 A 联合给药对急性肺损伤小鼠的 W/D 重量比、总蛋白(TP)水平和炎症细胞因子(TNF-α、IL-6、IL-1β 和 IL-17)水平具有更强的抑制作用。毛蕊异黄酮、毛蕊异黄酮苷和连翘酯苷 A 联合给药还改善了 LPS 诱导的急性肺损伤小鼠中炎性细胞的浸润和肺泡壁的增厚。更重要的是,三种化合物单独预处理可显著抑制与 TLR4/MAPK/NF-κB 信号通路相关的蛋白的上调和 IL-17 的激活,而三种化合物联合预处理则协同增强了各化合物的作用。
毛蕊异黄酮、毛蕊异黄酮苷和连翘酯苷 A 联合给药可协同改善 LPS 诱导的急性肺损伤小鼠的炎症反应,其机制可能与 TLR4/MAPK/NF-κB 信号通路和 IL-17 激活的抑制有关。